Invitation - BioContact Québec: The 19th Edition of the Bio-pharmaceutical Industry Annual Event

QUEBEC, Sept. 25, 2013 /CNW Telbec/ - The 19^th edition of BioContact Quebec, the international symposium on bio-pharmaceutical partnerships, will take place on October 2^nd and 3^rd.

For two days, representatives of almost 100 pharmaceutical and bio-pharmaceutical companies from Canada, the United States and Europe as well as some 150 participants from universities, consulting firms, venture capital companies and government representatives will be on site to exchange and develop business partnerships.

According to Martin Godbout, the President of the event, this year's event will feature many topics of interest for the bio-pharmaceutical industry, which has been experiencing major changes in the recent years. Some of the chosen subjects are:

• How to make a drug attractive to investors and major pharmaceutical companies;
• Are virtual biotechs becoming the standard?
• Augment strategies to be more successful in the new business model
• Who is funding the bio-pharmaceutical companies these days and what is taken into account?
• Orphan drugs and rare diseases: learn from the past to build for tomorrow.

This meeting of minds around the "Bio-pharmaceutical Partnership" will also be the very first edition of Amorchem's "Knock-out" event, the Quebec's innovative venture capital, during which pre-selected academic researchers will be competing with boldness "in the ring" to convince a jury composed of industry veterans of the marketability of their research project.  Christopher Hall, the columnist, humorist and host, will be the master of ceremonies for the event. The "winner" will have the opportunity to receive funding for his research project in the amount of $500,000. A first in Quebec!

Two renowned lecturers will be attending: Mr. Gary King, Executive Vice-President, International Operations, Myriad Genetics & Laboratories, who will be speaking on the "Developing Novel Genetic Tests and Companion Diagnostics", and Mr. Thomas R. Cannel, President and Executive Director of Merck Canada Inc., in a conference entitled "En partenariat au bénéfice de l'innovation et des soins centrés sur le patient".

Media advisory - To participate in the 19^th edition of BioContact Québec in the quality of MEDIA, accreditation must be requested from the pressroom co-ordinator (contact information below). For more information, please consult the complete program at the following address: www.biocontact.ca.

SOURCE: BIOCONTACT QUEBEC

Hélène Turcotte - Pressroom Co-ordinator
Telephone: [phone]
Cell phone: [phone]
E-mail: [email protected]